Lege Artis Medicinae

[Plasmaferesis for the treatment of acute pancreatitis related to extreme hypertriglyceridemia]

BELOPOTOCZKY Gábor, ORENTSÁK Áron, PÁRTOS Gergely, ARÁNYI József, HARIS Ágnes, PENYIGE József, SIKE Róbert, DEMETER Pál

MAY 20, 2017

Lege Artis Medicinae - 2017;27(04-05)

[We present the case of a 43-year-od wo­man, with pancreatitis related to extreme - higher than 100 mmol/L - secondary hy­pertriglyceridemia. Fast clinical improvement and rapid regression of pancreatitis were achieved by appropriate therapy of pancreatitis, the diabetic metabolic disturbance, correcting microcirculation and treating hypertriglyceridemia with plasmapheresis. The authors underline, that the complex therapeutic approach and early plasmapheresis in pancreatitis related to hypertriglyceridemia may prevent necrosis and more severe, even fatal, outcome of the disease. ]

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Vigilance for Drug Safety: the SCOPE Project – An Interview with Mick Foy, Pharmacovigilance Working Group Leader of the British Medicines Authority (MHRA) ]

CZIGLÉNYI Boglárka

Lege Artis Medicinae

[Subcutaneous interferon -1a in the treatment of clinically isolated syndromes: 3-year and 5 year results of the phase III dosing frequency-blind multicentre REFLEXION study]

KAPÓCS Gábor

Lege Artis Medicinae

[The Anatomic Theater – The Publicity of the Opened Body ]

CZIGLÉNYI Boglárka

Lege Artis Medicinae

[Rapprochement to medicine: crossing paths between Franz Alexander and Michael Polanyi]

KELEMEN Gábor

[Franz Alexander and Michael Polanyi, who were childhood friends, schoolmates at the grammar school as well as at the medical school are renowned scientists, who were dealing with the issue of reciprocity between knower and known. Interrelation of their careers is hardly researched. In this paper, I attend to this unexplored topic. Alexander adopted the Freudian position at the age of 29. Polanyi first had turned into a physical chemist and then, at the age of 45 his calling was in the philosophy of science. I will show in this paper that their achievements are deeply rooted in the culture that they acquiered in their medical studies in Hungary. ]

Lege Artis Medicinae

[The World and I are One – On the Photographs of Rinko Kawauchi ]

FARKAS Renáta

All articles in the issue

Related contents

Lege Artis Medicinae

[ENTERAL ADMINISTRATION OF N-3 POLYUNSATURATED FATTY ACIDS IN ACUTE PANCREATITIS]

LÁSZTITY Natália, HAMVAS József, BÍRÓ Lajos, NÉMETH Éva, MAROSVÖLGYI Tamás, DECSI Tamás, PAP Ákos, ANTAL Magda

[BACKGROUND - The main determinant of outcome in acute pancreatitis is the extent of inflammation and pancreatic necrosis. Early administration of n-3 polyunsaturated fatty acids (PUFAs) may prevent the development of severe complications through modulation of eicosanoid synthesis and cytokine release. PATIENTS AND METHODS - In the prospective, randomised clinical trial 14 patients with acute pancreatitis received n-3 PUFAs (3.3 g/day for 5- 7 days) as a supplement to their enteral formula in the form of fish oil, and another 14 patients receiving enteral nutrition served as a control group. Measurements of erythrocyte superoxidedysmutase activity, serum total antioxidant status, C-reactive protein and praealbumin concentrations were performed at admission and at day 3, 7 and 14. Beside routine laboratory and imaging examinations, the fatty acid and vitamin A and E concentrations of the serum lipid fractions were also determined at admission and at day 7 of the jejunal nutrition. The endpoints of the study were the duration of hospitalisation, the duration of jejunal nutrition and the frequency of complications. RESULTS - A significantly higher superoxidedysmutase activity was observed in patients receiving n-3 fatty acids at day 3 of the treatment. The n-3 to n-6 long chain PUFA ratio increased significantly in the serum lipids of the patients receiving n-3 PUFA supplementation, whereas remained unchanged in the controls. Supplementation resulted in a significant decrease in the length of hospitalisation (13.1±6.7 vs. 19.3±7.2 days, p<0.05) and jejunal feeding (10.6±6.7 vs. 17.6±10.5, p<0.05). Complications developed in 6/14 (42%) of the treated group and in 9/14 (64%) of the control patients. CONCLUSION - Enteral administration of n-3 PUFAs in acute pancreatitis may promote earlier recovery by moderating inflammation.]

LAM Extra for General Practicioners

[TREATMENT OF ACUTE PANCREATITIS, WITH SPECIAL REGARD TO PHARMACEUTICAL THERAPY]

DÖBRÖNTE Zoltán

[Treatment of acute pancreatitis is mainly supportive, including the correction of any factors causing or sustaining the disease process, efforts to limit complications, as well as treatment of complications. Pharmaceutical efforts to influence the pathophysiological events with protease inhibitors or by influencing the release of the pro-inflammatory cytokine cascade did not prove to be effective, so there is no known effective and specific drug therapy for clinical use. Adequate pain control is an important component of pharmaceutical management, and - although yet controversial - early antibiotic prophylaxis and effective antimicrobial treatment of the inflammatory complications (infected necrosis or fluid collection, SIRS, sepsis) have probably a determining role in the outcome of severe necrotizing pancreatitis. Carbapenems proved to be the most potent antibiotics. For the prevention of the not infrequent fungal superinfection in acute pancreatitis, early administration of fluconasole can also decrease mortality. Surgery is indicated in the first stage of infected necrosis and infected pancreatic and peripancreatic fluid collections. In certain patients with a high operative risk, endoscopic or percutaneous drainage with lavage can also be worth trying. Optimal conditions for the treatment of severe necrotizing pancreatitis, as well as adequate management of multiple organ failure can only be warranted at an intensive care unit. In the chemoprevention of pancreatitis complicating endoscopic retrograde cholangiopancreatography (ERCP), non-steroidal anti-inflammatory drugs promise a new therapeutic option. There are insufficient data about the beneficial effects of the protease inhibitor ulinastatin, and results with nitroglycerin are contradictory.]

Hungarian Immunology

[Changes in the signal transduction of T-lymphocytes caused by hyperglycemia]

BOLDIZSÁR Ferenc, BERKI Tímea, MISETA Attila, NÉMETH Péter

[AIMS - Lately the altered calcium balance of different cell types (eg.: erythrocytes, platelets, neutrophil granulocytes) was described in diabetes mellitus. It is also known that patients with diabetes mellitus suffer from various infections more often then healthy individuals because of immunological malfunctions. But the mechanism of these changes is still unclear. In order to investigate the effect of hyperglycemia on the function of immunocompetent cells we established an in vitro diabetes model by culturing human T cells (Jurkat cells) at different glucose concentrations for one week. Then we measured the basal cytosolic calcium level, the calcium signal after ionomycin or anti-CD3 treatment and the tyrosinephosphorylation of signal transducing proteins as well as the fructosamine level of cellular proteins. MATERIALS AND METHOD - Cytosolic free calcium levels were detected by flow cytometry using ion selective fluorescent indicator (Fluo-3 AM). Calcium signals of Jurkat cells were measured after ionomycin or monoclonal anti-CD3 antibody (OKT3) treatment. We also measured the tyrosine-phosphorylation on flow cytometer after anti-CD3 stimulation using indirect immunfluorescent labeling with monoclonal antiphospho- tyrosine antibody. The non-enzymatic glycation of cellular proteins was determined by measuring the fructosamine levels of cell lysates. RESULTS - The higher concentration of extracellular glucose resulted in concentration-dependent elevation of basal cytosolic free calcium level in Jurkat cells. Reduced calcium signal (activation capacity) was measured either after ionomycin or monoclonal anti-CD3 antibody treatments in cells kept at hyperglycemic conditions. In addition, the time kinetics of calcium signal following anti- CD3 activation was found prolonged in the hyperglycemic cells. The tyrosine-phosphorilation of hyperglycemic Jurkat cells also proved to be impaired. High glucose concentrations in tissue culture medium caused increase in the glycation of T-cell proteins. CONCLUSIONS - We propose that increased glycation of proteins involved in calcium transport and/or intracellular signal transduction of T-cells may account for our observations.]

Lege Artis Medicinae

[WAYS OF PREVENTION OF SEPTIC COMPLICATIONS IN ACUTE PANCREATITIS]

OLÁH Attila

[Similarly to other acute inflammatory responses, the mortality curve of acute pancreatitis has two distinct peaks. The first one, which coincides with a hyperinflammatory phase, is due to the development of an overwhelming systemic inflammatory response syndrome and subsequent multi-organ failure. The second peak of mortality is detected much later, after 14 days from the onset of the disease, when the compensatory antiinflammatory phase results in the infection of the necrotising pancreatic glandular substance. Since no therapy has been shown to efficiently prevent the activation of inflammatory and proteolytic cascades that evoke and sustain the disease, the treatment of acute pancreatitis is basically symptomatic. Beside adequate fluid and volume replacement and pain relief, medical and mechanical support may become necessary if organ failure develops. Recent studies suggest that there are ways to decrease the incidence of infection in pancreatic necrosis, which is usually due to bacterial translocation from the gut. The results of attempts to decrease the frequency of septic complications are controversial. A number of studies support the need of antibiotic prophylaxis but the evidence is weak. Furthermore, the increasingly observed infections by multi-resistant strains of Gram-positive bacteria and Candida species are due to long-term antibiotic use, which strongly questions the grounds for prophylactic antibiotic treatment. Recently, various clinical studies aimed to decrease bacterial translocation in other ways, including probiotic use and enteral feeding. This paper provides a systematic review of the data available in the evidence-based literature on the use of antibiotics and the role of alternative and adjuvant therapy in the treatment of severe acute pancreatitis.]

Lege Artis Medicinae

[Treatment of acute pancreatitis, with special regard to pharmaceutical therapy]

DÖBRÖNTE Zoltán

[Treatment of acute pancreatitis is mainly supportive, including the correction of any factors causing or sustaining the disease process, efforts to limit complications, as well as treatment of complications. Pharmaceutical efforts to influence the pathophysiological events with protease inhibitors or by influencing the release of the pro-inflammatory cytokine cascade did not prove to be effective, so there is no known effective and specific drug therapy for clinical use. Adequate pain control is an important component of pharmaceutical management, and - although yet controversial - early antibiotic prophylaxis and effective antimicrobial treatment of the inflammatory complications (infected necrosis or fluid collection, SIRS, sepsis) have probably a determining role in the outcome of severe necrotizing pancreatitis. Carbapenems proved to be the most potent antibiotics. For the prevention of the not infrequent fungal superinfection in acute pancreatitis, early administration of fluconasole can also decrease mortality. Surgery is indicated in the first stage of infected necrosis and infected pancreatic and peripancreatic fluid collections. In certain patients with a high operative risk, endoscopic or percutaneous drainage with lavage can also be worth trying. Optimal conditions for the treatment of severe necrotizing pancreatitis, as well as adequate management of multiple organ failure can only be warranted at an intensive care unit. In the chemoprevention of pancreatitis complicating endoscopic retrograde cholangiopancreatography (ERCP), non-steroidal anti-inflammatory drugs promise a new therapeutic option. There are insufficient data about the beneficial effects of the protease inhibitor ulinastatin, and results with nitroglycerin are contradictory.]